Teva Pharmaceuticals makes $40 billion bid for Mylan

The red hot market for big pharma deals just got hotter as Teva launched a hostile $40 billion bid for Mylan.

This entry was posted in Biotech & Pharmaceuticals, M&A, NBR Show Clips. Bookmark the permalink.

Leave a Reply